Evaluation of botulinum toxin A therapy in children with adductor spasm by gross motor function measure

Journal of Child Neurology

Volumn 15, Issue 4, 2000, Pages 214-217

  Mall, Volker ^c   Heinen, Florian ^b   Kirschner, Janbernd ^c   Linder, Michaela ^c   Stein, Sabine ^c   Michaelis, Ulla ^c   Bernius, Peter ^c   Lane, Mary ^a   Korinthenberg, Rudolf ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF FREIBURG   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADOLESCENT; ADULT; ARTICLE; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; DISABILITY; FEMALE; HUMAN; JOINT MOBILITY; MALE; MOTOR DYSFUNCTION; PRIORITY JOURNAL; SPASTICITY; TREATMENT OUTCOME;

EID: 0034082895     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380001500402     Document Type: Article

References (31)

1. Cosgrove AP, Cony IS, Graham HK: Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 1994;36:386-396.
2. Heinen F, Wissel J, Philipsen A, et al: Interventional neuropediatrics: Treatment of dystonic and spastic muscular hyperactivity with botulinum toxin A. Neuropediatrics 1997;28:307-313.
3. Mall V, Heinen F, Linder M, et al: Treatment of cerebral palsy with botulinum toxin A: Functional benefit and reduction of disability. Three case reports. Pediatr Rehabil 1997;1:235-237.
4. Schiavo G, Benfenati F, Poulain B, et al: Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 1992;359:832-835.
5. Ketelaar M, Vermeer A: Functional motor abilities of children with cerebral palsy: A systematic literature review of assessment measures. Clin Rehabil 1998;12:369-380.
6. Russell D, Rosenbaum P, Gowland C, et al: Gross Motor Function Measure Manual. Hamilton, ON, McMaster University, 1998.
7. Russell DJ, Rosenbaum PL, Cadman DT, et al: The gross motor function measure: A means to evaluate the effects of physical therapy. Dev Med Child Neurol 1989;31:341-352.
8. Palisano R, Rosenbaum P, Walter S, et al: Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997;39:214-223.
9. Ash worth B: Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1966;192:540-542.
10. Bohannon RW, Smith MB: Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987;67:206-207.
11. Haley SM, Coster WJ, Ruth MF: A content validity study of the pediatric evaluation of disability inventory. Pediatr Phys Ther 1991;3: 177-184.
12. Almeida GL, Campbell SK, Girolami GL, et al: Multidimensional assessment of motor function in a child with cerebral palsy following intrathecal administration of Baclofen. Phys Ther 1997;77: 751-764.
13. Boyce WF, Gowland C, Rosenbaum P, et al: Gross motor performance measure for children with cerebral palsy: Study design and preliminary findings. Can J Public Health 1992;83:34-40.
14. Campbell SK, Kolobe TH, Osten ET, et al: Construct validity of the test of infant motor performance. Phys Ther 1995;75:585-596.
15. Damiano DL, Abel MF: Relation of gait analysis to gross motor function in cerebral palsy. Dev Med Child Neurol 1996;38:389-396.
16. Damiano DL, Abel MF: Functional outcomes of strength training in spastic cerebral palsy. Arch Phys Med Rehabil 1998;79:119-125.
17. Drouin LM, Malouin F, Richards CL, Marcoux S: Correlation between the gross motor function measure scores and gait spatiotemporal measures in children with neurological impairments. Dev Med Child Neurol 1996;38:1007-1019.
18. Hays RM, McLaughlin JF, Bjornson KF, et al: Electrophysiological monitoring during selective dorsal rhizotomy, and spasticity and Gross Motor Function Measure performance. Dev Med Child Neurol 1998;40:233-238.
19. Hodgkinson I, Berard C, Jindrich ML, et al: Selective dorsal rhizotomy in children with cerebral palsy. Results in 18 cases at one year postoperatively. Stereotact Funct Neurosurg 1997;69:259-267.
20. Kolobe TH, Palisano RJ, Stratford PW: Comparison of two outcome measures for infants with cerebral palsy and infants with motor delays. Phys Ther 1998;78:1062-1072.
21. Law M, Russell D, Pollock N, et al: A comparison of intensive neurodevelopmental therapy plus casting and a regular occupational therapy program for children with cerebral palsy. Dev Med Child Neurol 1997;39:664-670.
22. McLaughlin JF, Bjornson KF, Astley SJ, et al: Selective dorsal rhizotomy: Efficacy and safety in an investigator-masked randomized clinical trial. Dev Med Child Neurol 1998;40:220-232.
23. Nordmark E, Hagglund G, Jarnlo GB: Reliability of the gross motor function measure in cerebral palsy. Scand J Rehabil Med 1997;29:25-28.
24. Palisano RJ, Kolobe TH, Haley SM, et al: Validity of the Peabody Developmental Gross Motor Scale as an evaluative measure of infants receiving physical therapy. Phys Ther 1995;75:939-948.
25. Parker DF, Carriere L, Hebestreit H, et al: Muscle performance and gross motor function of children with spastic cerebral palsy. Dev Med Child Neurol 1993;35:17-23.
26. Rosenbaum PL: Selective dorsal rhizotomy studies, letter. Dev Med Child Neurol 1998;40:717.
27. Russell D, Palisano R, Walter S, et al: Evaluating motor function in children with Down syndrome: Validity of the Gross Motor Function Measure. Dev Med Child Neurol 1998;40:693-701.
28. Steinbok P, Reiner AM, Beauchamp R, et al: A randomized clinical trial to compare selective posterior rhizotomy plus physiotherapy with physiotherapy alone in children with spastic diplegic cerebral palsy. Dev Med Child Neurol 1997;39:178-184.
29. Steinbok P, Reiner AM, Kestle JR: Therapeutic electrical stimulation following selective posterior rhizotomy in children with spastic diplegic cerebral palsy: A randomized clinical trial. Dev Med Child Neurol 1997;39:515-520.
30. Wright FV, Sheil EM, Drake JM, et al: Evaluation of selective dorsal rhizotomy for the reduction of spasticity in cerebral palsy: A randomized controlled trial. Dev Med Child Neurol 1998;40: 239-247.
31. Wright MJ, Halton JM, Martin RF, Barr RD: Long-term gross motor performance following treatment for acute lymphoblastic leukemia. Med Pediatr Oncol 1998;31:86-90.